I was skeptical...

Alexander Green's first impression of Oxford Club Strategist Marc Lichtenfeld was a skeptical one. But he quickly learned that Marc knew his stuff... including one of the best ways to profit from American innovation. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  [Liberty Through Wealth]( SPONSORED "Not the Deal Americans Were Promised!" Congress Passes Law That Could Reduce Retirement Accounts. [Details Here.](  Tell Us... How do you feel about the state of the U.S. economy? [Click here to answer.](  Wednesday Wealth Recap - With the coronavirus ripping through the economy, millions of Americans are worried about their financial stability. But despite all the stress, Alexander Green explains that [it's actually a great time to invest](. - Warren Buffett is often hailed as the greatest investor of all time. But Nicholas Vardy contends that the Oracle of Omaha has [lost his touch](. - If you've ever felt the system was rigged against you, Manward Press founder Andy Snyder has [some important advice]( for you... and it could change your life.  Note From Managing Editor Allison Brickell: I've been with The Oxford Club for more than five years now. So it's hard for me to imagine a time when Chief Income Strategist Marc Lichtenfeld wasn't a key member of our Oxford Club team (and a friendly face around our Baltimore office). But today we're taking a look back in time... to when Alexander Green wrote about his first impression of Marc. You see, Marc has a unique talent for [tracking biotech catalysts]( and playing them at the exact right time to return MAJOR profits. And his latest research has blown us away. Continue reading to see what Alex really thought about Marc all those years ago, and take a look at Marc's latest presentation [right here](. Marc believes that you can double your money 12 times over the next 12 months if you [use this one catalyst]( correctly. [Click here to watch his presentation.](  THE SHORTEST WAY TO A RICH LIFE First Impressions Could Cost You Alexander Green | Chief Investment Strategist | The Oxford Club [Alexander Green] In September 2007, I was at an Oxford Club conference in Lake Louise, Alberta. Our CEO and Executive Publisher Julia Guth and colleague Karim Rahemtulla kept raving about the Club's newest strategist. I was skeptical... The Club was just beginning to grow. I wanted to preserve its quality and reputation. So before I formally met him, I snuck into the back of his first presentation to Members. I figured I'd get an early first impression of the guy before happy hour. He was presenting on one of my favorite topics: biotech. At the time, his first Oxford Club recommendation, BioMarin Pharmaceutical (Nasdaq: BMRN), was up around 35%. (A few months later, he closed out the position for a gain of more than 100%.) While Marc and I may not see eye to eye on some things - I'd rather be on the golf course, while he'd rather be at the poker table - we agree on the things that really matter... Specifically, our investing strategies.  SPONSORED [Reclusive Trading Expert Releases COVID-19 Emergency Market Update Video...]( This newly released video reveals everything you need to do to protect and grow your money during this unprecedented public health crisis. [Click here to watch it now.](  We believe in the importance of investing for the long term, diversifying your portfolio, and using trailing stops to limit your downside and lock in your gains. We also agree that we live in an incredible country. American ingenuity, technology and capital markets have created dramatic improvements in communications, transportation, manufacturing, computing, retail, food production, construction, healthcare, finance, pharmaceuticals, robotics, sensors, artificial intelligence, genetics and dozens of other industries. We can't even imagine all the fantastic innovations that lie ahead of us - especially in terms of healthcare. It's easy to overlook the triumph of science over disease in the past 100 years. During this period, polio, smallpox, typhoid, tetanus, whooping cough, measles and diphtheria have all been controlled or eradicated. These victories helped double the human life span in the 20th century. In recent years, medical research has made significant inroads in the treatment of the nation's two biggest killers: heart disease and cancer. The National Cancer Institute reports that the risk of dying from cancer declined 22% between 1991 and 2011. Heart disease and stroke deaths have also fallen dramatically. Our longer, healthier lives have also created an economic benefit. In inflation-adjusted terms, Americans' per capita output is eight times what it was in the 19th century. Much of this is directly linked to progress against disease. Yet hundreds of diseases still cry out for effective cures or treatment. I've been arguing for years that the best way to play American innovation is with a careful selection of small cap and midcap biotechs. I learned early on that Marc has a knack for identifying such companies. (In 2007, BioMarin's market cap was around $2.5 billion. Today, it's $22 billion.) Last year, Marc partnered with former Speaker of the House Newt Gingrich for The 2019 American Health & Wealth Summit. During the summit, they discussed the investing and economic opportunities within the gene therapy subsector of biotech. Since then, gene therapy companies (as measured by a JPMorgan Genetic Therapies fund) have produced a total return of 37.48%. Meanwhile, the S&P 500 has returned a paltry 4.41% over the same period. [Gene Therapy Trounces the Broader Market]  Now Marc is researching [a catalyst that Wall Street has been using for nearly three decades]( to successfully play the biotech sector. And it has nothing to do with clinical trials or earnings reports. Using this catalyst, Marc believes investors can [double their money 12 times over 12 months](. Based on his track record, I know I'll be watching his latest presentation closely. [Click here to see Marc's latest biotech research.]( Good investing, Alex [Leave a Comment](  For Alex's latest video updates, subscribe on [YouTube](.  JOIN THE CONVERSATION [Facebook]( [Facebook]( [Twitter]( [Twitter]( [Email Share](mailto:?subject=A%20great%20piece%20from%20Liberty%20Through%20Wealth...&body=From%20Liberty%20Through%20Wealth:%0D%0A%0D%0AAlexander%20Green's%20first%20impression%20of%20Oxford%20Club%20Strategist%20Marc%20Lichtenfeld%20was%20a%20skeptical%20one.%20But%20he%20quickly%20learned%20that%20Marc%20knew%20his%20stuff...%20including%20one%20of%20the%20best%20ways%20to%20profit%20from%20American%20innovation.%0A%0D [Email Share](mailto:?subject=A%20great%20piece%20from%20Liberty%20Through%20Wealth...&body=From%20Liberty%20Through%20Wealth:%0D%0A%0D%0AAlexander%20Green's%20first%20impression%20of%20Oxford%20Club%20Strategist%20Marc%20Lichtenfeld%20was%20a%20skeptical%20one.%20But%20he%20quickly%20learned%20that%20Marc%20knew%20his%20stuff...%20including%20one%20of%20the%20best%20ways%20to%20profit%20from%20American%20innovation.%0A%0D  MORE FROM LIBERTY THROUGH WEALTH [Learn From Warren Buffett's Bad Investments](    [It's Never Been Easier to Build a Fortune](    [Black Wealth Matters - Here's How to Create More of It](  SPONSORED [The Perfect Time to Buy an IPO]( [Buy_Here_Decade](  One recent IPO is in the perfect buying position. Bloomberg's 2019 "stock picker of the year" picked up 6.5 million shares. And the lead investor behind Google and Amazon put in hundreds of millions. [Here's why RIGHT NOW is the perfect time to get in.](  [The Oxford Club](  You are receiving this email because you subscribed to Liberty Through Wealth. Liberty Through Wealth is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Liberty Through Wealth]( | [Unsubscribe]( © 2020 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#) [Oxfordclub.com](   The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.